Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1996-6-20
|
pubmed:abstractText |
Liposomes act as powerful adjuvants if physically associated with a protein antigen. Their effect on the immune response, however, varies with the nature of this linkage, surface-linked and encapsulated antigens having different properties. Cytometric analysis and cytokine measurements indicate that this difference may be due to the differential activation of T lymphocyte populations. Surface-linked antigen appears to preferentially stimulate CD4+ T cells to proliferate and mature into a typical Th1 phenotype; this is indicated by a positive shift in the CD4+/CD8+ ratio of sensitized splenocytes, a massive production of interferon-gamma, and the absence of interleukin-4 secretion. In contrast, encapsulated antigen, while stimulating spleen cell proliferation, does not significantly affect the CD4+/CD8+ ratio and induces only low levels of interferon-gamma production in the absence of interleukin-4 secretion. These results suggest that CD4+ and CD8+ populations are both expanded in response to encapsulated antigen but that neither typical Th1 nor Th2 phenotypes are induced. High-resolution immunocytochemical investigations show that this differential activation of T cell populations may be related to a different intracellular trafficking of antigens into professional antigen-presenting cells. Whereas surface-linked antigen remains predominantly in endosomal compartments where it may be associated with major histocompatibility (MHC) class II products for presentation to CD4+ T cells, encapsulated antigen escapes into the cytosol, reaching the MHC class I pathway for presentation to CD8+ T cells. The results therefore suggest that both liposomal antigens stimulate cell-mediated immunity albeit differently. This behavioral difference may be of practical importance in the design of adjuvants for the preferential potentiation of specific cytotoxic effector functions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-8749
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
169
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
208-17
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8620548-Adjuvants, Immunologic,
pubmed-meshheading:8620548-Animals,
pubmed-meshheading:8620548-Antigen-Presenting Cells,
pubmed-meshheading:8620548-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:8620548-Female,
pubmed-meshheading:8620548-Immunity, Cellular,
pubmed-meshheading:8620548-Liposomes,
pubmed-meshheading:8620548-Lymphocyte Activation,
pubmed-meshheading:8620548-Male,
pubmed-meshheading:8620548-Mice,
pubmed-meshheading:8620548-Mice, Inbred BALB C
|
pubmed:year |
1996
|
pubmed:articleTitle |
Differential activation of cell-mediated immune functions by encapsulated and surface-linked liposomal antigens.
|
pubmed:affiliation |
Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|